New collaboration builds on Sanofi’s prior acquisition of DR-0201 and further leverages Dren Bio’s proprietary Targeted Myeloid Engager and Phagocyt ...
Vor Biopharma has done well to continue to advance its very own global phase 3 study using its dual BAFF/APRIL inhibitor ...
Neoantigen vaccines are at the forefront of cancer research, driving personalized immunotherapy and improving outcomes ...
The OnePlus 15R is sitting in a pretty interesting place, especially in the US market. It is the OnePlus "cheaper" flagship ...
Gokin has launched back-contact solar modules ranging from 480 W to 780 W for residential, commercial, industrial, and ...
The company secured $47 million through extension rounds of Series A led by Legend Capital and Meituan Long-Z Investment with ...
HELIOS-B is a global, randomized, double-blind, placebo-controlled clinical trial that evaluated the efficacy and safety of AMVUTTRA (R) in adult patients with wtATTR or hATTR amyloidosis with ...
Analyzing stochastic cell-to-cell variability can potentially reveal causal interactions in gene regulatory networks.
Issued on behalf of GT Biopharma, Inc. VANCOUVER, BC, Dec. /CNW/ — Equity Insider News Commentary – November’s wave of FDA oncology approvals signals the industry’s shift toward ...
Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that Revuforj ® (revumenib) was named Best New Drug at the ...
The two economics chapters in NCERT’s Class 7 Social Science Part-2 textbook, present a contemporary picture of India’s ...
Students of Class 7 studying through NCERT textbooks will now explore India’s timeless philosophy of Vasudhaiva Kutumbakam as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results